Mouse Tumor Biology (MTB): A database of mouse models for human cancer

Nucleic Acids Research

Volumn 43, Issue D1, 2015, Pages D818-D824

  Bult, Carol J ^a   Krupke, Debra M ^a   Begley, Dale A ^a   Richardson, Joel E ^a   Neuhauser, Steven B ^a   Sundberg, John P ^a   Eppig, Janan T ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; BIOINFORMATICS; CANCER GENETICS; CANCER RESEARCH; CARCINOGENESIS; DATA BASE; DATA MINING; DATA PROCESSING; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; INFORMATION SYSTEM; MEDICAL TERMINOLOGY; METASTASIS; MOUSE MODEL; MOUSE STRAIN; NOMENCLATURE; ONLINE SYSTEM; PEER REVIEW; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SCIENTIFIC LITERATURE; TRANSLATIONAL RESEARCH; TUMOR CLASSIFICATION; TUMOR MODEL; TUMOR XENOGRAFT; ANIMAL; DISEASE MODEL; EXPERIMENTAL NEOPLASM; GENETIC DATABASE; GENETICS; INTERNET; MOUSE; PATHOLOGY;

ANIMALS; DATABASES, GENETIC; DISEASE MODELS, ANIMAL; GENOMICS; INTERNET; MICE; NEOPLASMS, EXPERIMENTAL; QUANTITATIVE TRAIT LOCI;

EID: 84941034401     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku987     Document Type: Article

References (46)

1. Rosenthal, N. and Brown, S. (2007) The mouse ascending: perspectives for human-disease models. Nat. Cell Biol., 9, 993-999.
2. Justice, M. J., Siracusa, L. D. and Stewart, A. F. (2011) Technical approaches for mouse models of human disease. Dis. Models Mech., 4, 305-310.
3. Paigen, K. (1995) A miracle enough: the power of mice. Nat. Med., 1, 215-220.
4. Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E. and Church, G. M. (2013) RNA-guided human genome engineering via Cas9. Science, 339, 823-826.
5. Ewart-Toland, A. and Balmain, A. (2004) The genetics of cancer susceptibility: from mouse to man. Toxicol. Pathol., 32(Suppl. 1), 26-30.
6. Quigley, D. and Balmain, A. (2009) Systems genetics analysis of cancer susceptibility: from mouse models to humans. Nat. Rev. Genet., 10, 651-657.
7. Demant, P. (2003) Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat. Rev. Genet., 4, 721-734.
8. Politi, K. and Pao, W. (2011) How genetically engineered mouse tumor models provide insights into human cancers. J. Clin. Oncol., 29, 2273-2281.
9. McGonigle, P. and Ruggeri, B. (2014) Animal models of human disease: challenges in enabling translation. Biochem. Pharmacol., 87, 162-171.
10. Kopetz, S., Lemos, R. and Powis, G. (2012) The promise of patient-derived xenografts: the best laid plans of mice and men. Clin. Cancer Res., 18, 5160-5162.
11. Walrath, J. C., Hawes, J. J., Van Dyke, T. and Reilly, K. M. (2010) Genetically engineered mouse models in cancer research. Adv. Cancer Res., 106, 113-164.
12. Khaled, W. T. and Liu, P. (2014) Cancer mouse models: past, present and future. Semin. Cell Dev. Biol., 27, 54-60.
13. Malaney, P., Nicosia, S. V. and Dave, V. (2014) One mouse, one patient paradigm: new avatars of personalized cancer therapy. Cancer Lett., 344, 1-12.
14. Sundberg, J. P., Roopenian, D. C., Liu, E. T. and Schofeld, P. N. (2013) The Cinderella effect: searching for the best ft between mouse models and human diseases. J. Invest. Dermatol., 133, 2509-2513.
15. Nielsen, L. L., Discafani, C. M., Gurnani, M. and Tyler, R. D. (1991) Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. Cancer Res., 51, 3762-3767.
16. Nielsen, L. L., Gurnani, M., Catino, J. J. and Tyler, R. D. (1995) In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background. Anticancer Res., 15, 385-392.
17. Genik, P. C., Bielefeldt-Ohmann, H., Liu, X., Story, M. D., Ding, L., Bush, J. M., Fallgren, C. M. and Weil, M. M. (2014) Strain background determines lymphoma incidence in Atm knockout mice. Neoplasia, 16, 129-136.
18. Roberts, R. B., Arteaga, C. L. and Threadgill, D. W. (2004) Modeling the cancer patient with genetically engineered mice: prediction of toxicity from molecule-targeted therapies. Cancer Cell, 5, 115-120.
19. Shultz, L. D., Brehm, M. A., Garcia-Martinez, J. V. and Greiner, D. L. (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol., 12, 786-798.
20. Shultz, L. D., Ishikawa, F. and Greiner, D. L. (2007) Humanized mice in translational biomedical research. Nat. Rev. Immunol., 7, 118-130.
21. Brehm, M. A., Shultz, L. D. and Greiner, D. L. (2010) Humanized mouse models to study human diseases. Curr. Opin. Endocrinol. Diabetes Obes., 17, 120-125.
22. Zhou, Q., Facciponte, J., Jin, M., Shen, Q. and Lin, Q. (2014) Humanized NOD-SCID IL2rg (-/-) mice as a preclinical model for cancer research and its potential use for individualized cancer therapies. Cancer Lett., 344, 13-19.
23. Shultz, L. D., Goodwin, N., Ishikawa, F., Hosur, V., Lyons, B. L. and Greiner, D. L. (2014) Human cancer growth and therapy in immunodeficient mouse models. Mouse Models of Cancer: A Laboratory Manual. Cold Spring Harbor Press Protocols, NY.
24. Bult, C. J., Krupke, D. M. and Eppig, J. T. (1999) Electronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project. Nucleic Acids Res., 27, 99-105.
25. Mardis, E. R. and Wilson, R. K. (2009) Cancer genome sequencing: a review. Hum. Mol. Genet., 18, R163-R168.
26. Siolas, D. and Hannon, G. J. (2013) Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res., 73, 5315-5319.
27. Sundberg, J. P. and Schofeld, P. N. (2009) A mouse by any other name. J. Invest. Dermatol., 129, 1599-1601.
28. Gray, K. A., Daugherty, L. C., Gordon, S. M., Seal, R. L., Wright, M. W. and Bruford, E. A. (2013) Genenames.org: the HGNC resources in 2013. Nucleic Acids Res., 41, D545-D552.
29. Ahmad, I., Singh, L. B., Foth, M., Morris, C. A., Taketo, M. M., Wu, X. R., Leung, H. Y., Sansom, O. J. and Iwata, T. (2011) K-Ras and beta-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder. Dis. Models Mech., 4, 548-555.
30. Kogan, S. C., Ward, J. M., Anver, M. R., Berman, J. J., Brayton, C., Cardiff, R. D., Carter, J. S., de Coronado, S., Downing, J. R., Fredrickson, T. N. et al. (2002) Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood, 100, 238-245.
31. Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C. et al. (2004) Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res., 64, 2307-2316.
32. Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefeld, L. M. et al. (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene, 19, 968-988.
33. Washington, M. K., Powell, A. E., Sullivan, R., Sundberg, J. P., Wright, N., Coffey, R. J. and Dove, W. F. (2013) Pathology of rodent models of intestinal cancer: progress report and recommendations. Gastroenterology, 144, 705-717.
34. Weiss, W. A., Israel, M., Cobbs, C., Holland, E., James, C. D., Louis, D. N., Marks, C., McClatchey, A. I., Roberts, T., Van Dyke, T. et al. (2002) Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene, 21, 7453-7463.
35. Hruban, R. H., Rustgi, A. K., Brentnall, T. A., Tempero, M. A., Wright, C. V. and Tuveson, D. A. (2006) Pancreatic cancer in mice and man: the Penn Workshop 2004. Cancer Res., 66, 14-17.
36. Pienta, K. J., Abate-Shen, C., Agus, D. B., Attar, R. M., Chung, L. W., Greenberg, N. M., Hahn, W. C., Isaacs, J. T., Navone, N. M., Peehl, D. M. et al. (2008) The current state of preclinical prostate cancer animal models. Prostate, 68, 629-639.
37. Schofeld, P. N., Gruenberger, M. and Sundberg, J. P. (2010) PathBase and the MPATH ontology. Community resources for mouse histopathology. Vet. Pathol., 47, 1016-1020.
38. Begley, D. A., Krupke, D. M., Vincent, M. J., Sundberg, J. P., Bult, C. J. and Eppig, J. T. (2007) Mouse Tumor Biology Database (MTB): status update and future directions. Nucleic Acids Res., 35, D638-D642.
39. Drinkwater, N. R. and Gould, M. N. (2012) The long path from QTL to gene. PLoS Genet., 8, e1002975.
40. Blake, J. A., Bult, C. J., Eppig, J. T., Kadin, J. A., Richardson, J. E. and Mouse Genome Database, G. (2014) The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res., 42, D810-D817.
41. Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M. et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res., 41, D991-D995.
42. Rustici, G., Kolesnikov, N., Brandizi, M., Burdett, T., Dylag, M., Emam, I., Farne, A., Hastings, E., Ison, J., Keays, M. et al. (2013) ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res., 41, D987-D990.
43. Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
44. Bradley, A., Anastassiadis, K., Ayadi, A., Battey, J. F., Bell, C., Birling, M. C., Bottomley, J., Brown, S. D., Burger, A., Bult, C. J. et al. (2012) The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm. Genome, 23, 580-586.
45. Brown, S. D. and Moore, M. W. (2012) The International Mouse Phenotyping Consortium: past and future perspectives on mouse phenotyping. Mamm. Genome, 23, 632-640.
46. Svenson, K. L., Gatti, D. M., Valdar, W., Welsh, C. E., Cheng, R., Chesler, E. J., Palmer, A. A., McMillan, L. and Churchill, G. A. (2012) High-resolution genetic mapping using the Mouse Diversity outbred population. Genetics, 190, 437-447.